News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Drew Moghanaki: HORIZON-01 – ChemoRadiotherapy followed by Alectinib, Entrectinib, or Pralsetinib
Drew Moghanaki/X
May 18, 2025, 10:14

Drew Moghanaki: HORIZON-01 – ChemoRadiotherapy followed by Alectinib, Entrectinib, or Pralsetinib

Drew Moghanaki, Chief Medical Officer at Respirati, posted on X:

“Just when you thought the horizon for locally advanced NSCLC couldn’t get brighter… along comes HORIZON-01: ChemoRadiotherapy followed by Alectinib, Entrectinib, or Pralsetinib.
Thanks Millie Das for the heads up.”

Drew Moghanaki: HORIZON-01 - ChemoRadiotherapy followed by Alectinib, Entrectinib, or Pralsetinib

Other posts featuring Drew Moghanaki on OncoDaily.

ATS2025 cancer chemoradiotherapy Drew Moghanaki Millie Das NSCLC OncoDaily Oncology
Special Coverage
Blog
Jul 1, 2025, 17:10
Wafaa M Rashed: PAPERI Turns One with Bright Minds Episode Featuring Sarah Tishkoff
Blog
Jul 1, 2025, 17:00
Organ Preservation Strategies in Rectal Cancer - Asia-Pacific Gastroenterology Cancer Summit
Positive
Jul 1, 2025, 16:47
Nation-Leading Heart Surgery Milestone - St. Elizabeth Healthcare
Societies
Jul 1, 2025, 16:16
Latest Research Findings in GI Cancers from ESMO Ambassadors
Oncolibrary
Jul 1, 2025, 12:44
MASCC 2025 Highlights: StrataXRT Prevents Severe Radiation Dermatitis in Large-Breasted Women Undergoing Prone Breast Radiotherapy
Blog
Jul 1, 2025, 10:46
INTERACT-EUROPE 100 Has Launched a New Round of Recruitment - European Cancer Organisation
Societies
Jul 1, 2025, 10:32
25 Posts Not To Miss From MASCC 2025
Blog
Jul 1, 2025, 10:30
Alina Comanescu: Urgent Call to Action - Don't Let Cancer Slip Off the EU Agenda
Blog
Jul 1, 2025, 10:16
Survivor Cindy Pursues Nursing in Ghana Fifteen Years After Kidney Cancer Diagnosis - World Child Cancer
Blog
Jul 1, 2025, 10:07
Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe - EORTC
Blog
Jul 1, 2025, 09:57
Gevorg Tamamyan: To Me, MD Anderson Has Always Meant Dr. Kantarjian
Career
Jul 1, 2025, 09:56
Sidney Chahonyo is Breaking Barriers as the First Survivor on the Board of Childhood Cancer International